GLP-1 Drug Usage & Affordability in the US: A Recent Study
A new study reveals rising GLP-1 drug use in the US, especially among diabetics (45%). Cost remains a major concern, with many struggling to afford these medications despite insurance coverage. Medicare changes are coming.
